Drugs / Ultracet
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | ULTRACET | — | 2001-08-15 | fda.gov ↗ |
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02465866 Comparator | Nov 2014 → Apr 2015 | — | Charleston Laboratories, Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ultracet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02465866 ↗ |
| Route | Oral | “single dose tablet by mouth” NCT02465866 ↗ |